Department of Internal Medicine, Pusan National University School of Medicine, Busan, Republic of Korea.
Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Republic of Korea.
Respiration. 2022;101(4):401-407. doi: 10.1159/000520034. Epub 2021 Nov 19.
Radial probe endobronchial ultrasound-guided transbronchial lung biopsy (RP-EBUS-TBLB) is widely used for diagnosis of peripheral lung lesions (PLLs). To date, there have been no reports regarding the clinical outcomes of RP-EBUS-TBLB for PLLs in patients with idiopathic pulmonary fibrosis (IPF).
This study was performed between October 2017 and December 2019 to identify the safety and diagnostic performance of RP-EBUS-TBLB in IPF patients.
Patients were divided into the usual interstitial pneumonia (UIP) group (n = 39, 4%), the probable UIP group (n = 12, 1%), and the noninterstitial lung disease (non-ILD) group (n = 903, 95%).
The diagnostic yield was significantly lower in the UIP group than in the non-ILD group (62% vs. 76%; p = 0.042), but there were no significant differences between the UIP and probable UIP groups (62% vs. 83%; p = 0.293) or the probable UIP and non-ILD groups (83% vs. 76%; p = 0.741). Multivariate logistic analysis showed that the mean diameter of PLLs, positive bronchus sign on CT, and "within the lesion" status on EBUS were independently associated with success of the procedure. Especially, the presence of the UIP pattern on CT (OR, 0.385; 95% CI: 0.172-0.863; p = 0.020) was independently associated with failed diagnosis. Among patients with UIP, "within the lesion" status on EBUS (OR, 25.432; 95% CI: 2.321-278.666; p = 0.008) was shown to be a factor contributing to a successful diagnosis. Overall, there were no significant differences in complication rates among the 3 study groups.
RP-EBUS-TBLB can be performed safely with an acceptable diagnostic yield, even in patients with IPF.
经支气管径向探头超声引导下经支气管肺活检(RP-EBUS-TBLB)广泛应用于外周肺部病变(PLLs)的诊断。迄今为止,尚无关于特发性肺纤维化(IPF)患者的 RP-EBUS-TBLB 用于 PLLs 的临床结果的报道。
本研究于 2017 年 10 月至 2019 年 12 月进行,旨在确定 RP-EBUS-TBLB 在 IPF 患者中的安全性和诊断性能。
患者分为寻常型间质性肺炎(UIP)组(n=39,4%)、可能 UIP 组(n=12,1%)和非间质性肺疾病(non-ILD)组(n=903,95%)。
UIP 组的诊断率明显低于 non-ILD 组(62%比 76%;p=0.042),但 UIP 组与可能 UIP 组之间(62%比 83%;p=0.293)或可能 UIP 组与 non-ILD 组之间(83%比 76%;p=0.741)无显著差异。多变量逻辑分析显示,PLLs 的平均直径、CT 上的阳性支气管征和 EBUS 上的“在病变内”状态与手术成功率独立相关。特别是 CT 上存在 UIP 模式(OR,0.385;95%CI:0.172-0.863;p=0.020)与诊断失败独立相关。在 UIP 患者中,EBUS 上的“在病变内”状态(OR,25.432;95%CI:2.321-278.666;p=0.008)被证明是成功诊断的一个因素。总体而言,3 个研究组的并发症发生率无显著差异。
即使在 IPF 患者中,RP-EBUS-TBLB 也可以安全进行,且具有可接受的诊断率。